City Drug House Exporters | Hepatitis Medicines Supplier to Washington, USA
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
Myhep Dvir is a fixed-dose combination oral antiviral medication used to treat chronic Hepatitis C virus (HCV) infection. It contains Sofosbuvir (400 mg) and Daclatasvir (60 mg), working together as direct-acting antivirals (DAAs) to disrupt viral replication and clear the virus from the blood.
Mechanism of Action :
Myhep Dvir achieves a high cure rate by attacking the Hepatitis C virus at two different stages of its life cycle simultaneously:
Sofosbuvir: Acts as a nucleotide analog inhibitor of the viral RNA polymerase (NS5B protein). It incorporates into the replicating viral RNA, acting as a chain terminator to stop viral multiplication.
Daclatasvir: Functions as a pangenotypic inhibitor of the NS5A protein, which is crucial for viral replication and the assembly of new virus particles.
Pharmacokinetics :
Absorption: Both drugs are rapidly absorbed after oral administration. Sofosbuvir has peak plasma concentrations within 0.5 to 2 hours, and Daclatasvir reaches peak levels in about 1.5 to 2 hours.
Metabolism: Sofosbuvir is heavily metabolized in the liver to its active pharmacological form. Daclatasvir is primarily metabolized in the liver by the cytochrome P450 3A (CYP3A) system.
Excretion: Sofosbuvir and its active metabolite are primarily excreted via the kidneys (urine) and feces. Daclatasvir is mainly eliminated through feces and minimally through urine.
Indications & Dosage :
Standard Adult Dose: Typically, one tablet containing Sofosbuvir (400 mg) and Daclatasvir (60 mg) taken orally once daily.
Duration: Treatment duration typically spans 12 to 24 weeks depending on the HCV genotype, whether the patient has cirrhosis, and prior treatment history.
Guidelines: Treatment must be initiated and monitored by a healthcare professional experienced in chronic HCV management.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
Myhep Dvir is a fixed-dose combination oral antiviral medication used to treat chronic Hepatitis C virus (HCV) infection. It contains Sofosbuvir (400 mg) and Daclatasvir (60 mg), working together as direct-acting antivirals (DAAs) to disrupt viral replication and clear the virus from the blood.
Mechanism of Action :
Myhep Dvir achieves a high cure rate by attacking the Hepatitis C virus at two different stages of its life cycle simultaneously:
Sofosbuvir: Acts as a nucleotide analog inhibitor of the viral RNA polymerase (NS5B protein). It incorporates into the replicating viral RNA, acting as a chain terminator to stop viral multiplication.
Daclatasvir: Functions as a pangenotypic inhibitor of the NS5A protein, which is crucial for viral replication and the assembly of new virus particles.
Pharmacokinetics :
Absorption: Both drugs are rapidly absorbed after oral administration. Sofosbuvir has peak plasma concentrations within 0.5 to 2 hours, and Daclatasvir reaches peak levels in about 1.5 to 2 hours.
Metabolism: Sofosbuvir is heavily metabolized in the liver to its active pharmacological form. Daclatasvir is primarily metabolized in the liver by the cytochrome P450 3A (CYP3A) system.
Excretion: Sofosbuvir and its active metabolite are primarily excreted via the kidneys (urine) and feces. Daclatasvir is mainly eliminated through feces and minimally through urine.
Indications & Dosage :
Standard Adult Dose: Typically, one tablet containing Sofosbuvir (400 mg) and Daclatasvir (60 mg) taken orally once daily.
Duration: Treatment duration typically spans 12 to 24 weeks depending on the HCV genotype, whether the patient has cirrhosis, and prior treatment history.
Guidelines: Treatment must be initiated and monitored by a healthcare professional experienced in chronic HCV management.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
